SCHEMBL10104429

SCHEMBL10104429

Cc1cc(N2CCNC(C)C2)cc(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.50
FFAR4 Q5NUL3 2/20 0.43
HTR2C P28335 2/20 0.41
KHK P50053 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
HTR1D P28221 1/20 0.39
HTR3A P46098 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
DPP4 P27487 3/20 0.39
MAPT P10636 2/20 0.38
THRB P10828 1/20 0.38
PHGDH O43175 2/20 0.36
HSD11B1 P28845 1/20 0.36
XIAP P98170 1/20 0.36
BIRC2 Q13490 1/20 0.36
BCL2A1 Q16548 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2252772 0.91 ADRB1 (0.60) ADRB1FFAR4HTR2CKHKALDH1A1
SCHEMBL28794168 0.85 KHK (0.46) ADRB1HTR2CKHKALDH1A1MAPT
SCHEMBL10104425 0.84 FFAR4 (0.43) ADRB1FFAR4HTR2CALDH1A1HTR3E
SCHEMBL10104274 0.80 ADRB1 (0.77) ADRB1FFAR4HTR2CALDH1A1HTR3E
SCHEMBL12153158 0.79 NOTUM (0.49) ADRB1HTR2CKHKALDH1A1HTR3E
SCHEMBL2246874 0.79 NOTUM (0.49) ADRB1HTR2CKHKALDH1A1HTR3E
SCHEMBL8271861 0.79 NOTUM (0.49) ADRB1HTR2CKHKALDH1A1HTR3E
SCHEMBL25745795 0.79 FFAR4 (0.45) ADRB1FFAR4ALDH1A1DPP4MAPT
SCHEMBL15871377 0.76 FFAR4 (0.42) ADRB1FFAR4DPP4PHGDH
SCHEMBL10104300 0.75 FFAR4 (0.49) ADRB1FFAR4ALDH1A1DPP4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778929-B2 Substituted heteroaryl inhibitors of B-RAF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-15 US disclosed
US-8653087-B2 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-02-18 US disclosed
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 US disclosed
US-20110312939-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312939-A1 NEW CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 ADRB1 940/4885FFAR4 4204/4885HTR2C 2673/4885
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS CCNT1, CCNA1, CCND1 ADRB1 1165/4885FFAR4 2848/4885HTR2C 2276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.